ThursdayFeb 01, 2018 3:29 pm

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Teams with UniQuest to Develop Novel Cannabinoid Delivery System

Global nasal drug delivery technology market expected to reach $64 billion by 2021 Development of CBD-infused soluble gel for nasal delivery targets range of diseases Clinical benefits of Sol-gel delivery method include a safer, more reliable delivery platform with higher efficacy Health sciences company PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) and UniQuest Pty Limited, the main commercialization company of the University of Queensland (UQ), Australia, are expecting 2018 to be an exciting, productive year for joint medical research projects. PreveCeutical Medical, headquartered in Vancouver, British Columbia, has entered into a research and option agreement with the University and…

Continue Reading

ThursdayFeb 01, 2018 2:18 pm

EVIO, Inc. (EVIO) Provides a Critical Service to the Regulated Cannabis Industry

EVIO is a leading accredited provider of analytical services to the regulated cannabis industry The company currently operates nine laboratories in five states EVIO is on track to open 18 labs around the U.S. by the end of 2018 EVIO, Inc. (OTCQB: EVIO) provides clients across the United States with consistent, high-quality cannabis analytical services. Backed by a stringent quality control assurance program, the company’s laboratory division, EVIO Labs, is the leading provider of accredited analytical testing, scientific research and advisory services to enterprises in the U.S. regulated cannabis industry. The ancillary services provided by EVIO Labs are state-mandated, requiring…

Continue Reading

ThursdayFeb 01, 2018 12:04 pm

Golden Leaf Holdings, Ltd. (OTCQB: GLDFF) (CSE: GLH) Subsidiary Receives First Genetics at Ontario Plant-Growing Facility

Company plans mid-2018 commencement of adult-use market sales in Canada as it addresses medical segment opportunity The firm received its cultivation license during the fourth quarter of 2017, anticipates receiving its sales license by May Phillip Millar, MMG president, said company’s portfolio includes genetic strain that holds the highest level of CBD in Canada, sees potential in medical segment and for European export Golden Leaf Holdings, Ltd. (OTCQB: GLDFF) (CSE: GLH) recently announced that its subsidiary, Medical Marijuana Group ("MMG"), has received its first order of genetics at its St. Thomas, Ontario facility as it transitions from a production location…

Continue Reading

HempWireNews Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 303.498.7722